Literature DB >> 20182558

Antihemophilic Factor/von Willebrand Factor Complex (Human), Dried, Pasteurized.

.   

Abstract

Entities:  

Year:  2010        PMID： 20182558      PMCID： PMC2816145     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


× No keyword cloud information.
  48 in total

Review 1.  Retrospective review of the management of elective surgery with desmopressin and clotting factor concentrates in patients with von Willebrand disease.

Authors:  I C Nitu-Whalley; A Griffioen; C Harrington; C A Lee
Journal:  Am J Hematol       Date:  2001-04       Impact factor: 10.047

2.  The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study.

Authors:  Paula D James; Colleen Notley; Carol Hegadorn; Jayne Leggo; Angie Tuttle; Shawn Tinlin; Christine Brown; Chandler Andrews; Andrea Labelle; Yvette Chirinian; Lee O'Brien; Maha Othman; Georges Rivard; Dilys Rapson; Christine Hough; David Lillicrap
Journal:  Blood       Date:  2007-01-01       Impact factor: 22.113

3.  Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study.

Authors:  Pier M Mannucci; Juan Chediak; Wahid Hanna; John Byrnes; Marlies Ledford; Bruce M Ewenstein; Anastassios D Retzios; Barbara A Kapelan; Richard S Schwartz; Craig Kessler
Journal:  Blood       Date:  2002-01-15       Impact factor: 22.113

4.  von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia.

Authors:  L De Marco; A Girolami; T S Zimmerman; Z M Ruggeri
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

5.  Characterization of factor VIII/von Willebrand factor concentrates using a modified method of von Willebrand factor multimer analysis.

Authors:  H J Metzner; P Hermentin; T Cuesta-Linker; S Langner; H G Müller; J Friedebold
Journal:  Haemophilia       Date:  1998       Impact factor: 4.287

6.  Von Willebrand disease as cause of unanticipated bleeding following adeno-tonsillectomy.

Authors:  J I de Diego; M P Prim; E Rodriguez; J Garcia; M Morado
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1999-08-20       Impact factor: 1.675

7.  Type 2M:Milwaukee-1 von Willebrand disease: an in-frame deletion in the Cys509-Cys695 loop of the von Willebrand factor A1 domain causes deficient binding of von Willebrand factor to platelets.

Authors:  D J Mancuso; P A Kroner; P A Christopherson; E A Vokac; J C Gill; R R Montgomery
Journal:  Blood       Date:  1996-10-01       Impact factor: 22.113

8.  Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation.

Authors:  L De Marco; A Girolami; S Russell; Z M Ruggeri
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

Review 9.  Plasma product treatment in various types of von Willebrand's disease.

Authors:  E Berntorp
Journal:  Haemostasis       Date:  1994 Sep-Oct

10.  Successful treatment for patients with von Willebrand disease undergoing urgent surgery using factor VIII/VWF concentrate (Humate-P).

Authors:  A R Thompson; J C Gill; B M Ewenstein; G Mueller-Velten; B A Schwartz
Journal:  Haemophilia       Date:  2004-01       Impact factor: 4.287
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.